Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Autoliv
ALV
$9.09B
| $5.79M | ﹤0.01% |
67,507
+38,346
| +131% | +$3.54M |
|
1702
iShares US Medical Devices ETF
IHI
$3.14B
| $5.79M | ﹤0.01% |
92,166
-15,516
| -14% | -$990K |
|
|
CVET
1703
DELISTED
Covetrus, Inc. Common Stock
CVET
| $5.78M | ﹤0.01% |
318,859
+237,092
| +290% | +$5.44M |
|
1704
PUT
Seagate
STX
$169B
| $5.78M | ﹤0.01% |
70,000
| – | – |
|
1705
Vanguard High Dividend Yield ETF
VYM
$81.9B
| $5.77M | ﹤0.01% |
55,827
-70,964
| -56% | -$7.5M |
|
1706
uniQure
QURE
$2.52B
| $5.77M | ﹤0.01% |
180,250
+27,009
| +18% | +$823K |
|
1707
DigitalOcean
DOCN
$13.2B
| $5.76M | ﹤0.01% |
74,212
+73,399
| +9,028% | +$4.54M |
|
|
COHR
1708
DELISTED
Coherent Inc
COHR
| $5.76M | ﹤0.01% |
23,036
-59,808
| -72% | -$15M |
|
|
ZNGA
1709
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $5.76M | ﹤0.01% |
765,000
| – | – |
|
1710
Aramark
ARMK
$15.1B
| $5.76M | ﹤0.01% |
242,727
-21,688
| -8% | -$537K |
|
1711
Pan American Silver
PAAS
$18.2B
| $5.75M | ﹤0.01% |
247,173
+39,590
| +19% | +$1.03M |
|
1712
Churchill Downs
CHDN
$6.22B
| $5.74M | ﹤0.01% |
47,844
-16,362
| -25% | -$1.66M |
|
1713
CALL
Bausch Health
BHC
$1.69B
| $5.73M | ﹤0.01% |
+205,600
| New | +$5.83M |
|
1714
Texas Pacific Land
TPL
$26.9B
| $5.73M | ﹤0.01% |
42,633
+22,032
| +107% | +$3.43M |
|
1715
Travere Therapeutics
TVTX
$5.2B
| $5.72M | ﹤0.01% |
235,827
+25,308
| +12% | +$465K |
|
1716
MakeMyTrip
MMYT
$5.05B
| $5.72M | ﹤0.01% |
210,163
-42,297
| -17% | -$1.14M |
|
|
HPP
1717
Hudson Pacific Properties
HPP
$765M
| $5.71M | ﹤0.01% |
31,063
-9,838
| -24% | -$1.85M |
|
1718
PUT
Best Buy
BBY
$18.9B
| $5.71M | ﹤0.01% |
54,000
| – | – |
|
1719
CALL
American Airlines Group
AAL
$10.2B
| $5.65M | ﹤0.01% |
275,500
+115,500
| +72% | +$2.34M |
|
|
MDP
1720
DELISTED
Meredith Corporation
MDP
| $5.65M | ﹤0.01% |
101,490
-158,386
| -61% | -$6.91M |
|
1721
CALL
EOG Resources
EOG
$74.4B
| $5.65M | ﹤0.01% |
70,400
| – | – |
|
1722
Flowers Foods
FLO
$1.6B
| $5.65M | ﹤0.01% |
239,088
+40,399
| +20% | +$959K |
|
1723
BlackLine
BL
$1.87B
| $5.65M | ﹤0.01% |
47,828
-27,579
| -37% | -$3.17M |
|
1724
iShares Global 100 ETF
IOO
$8.72B
| $5.64M | ﹤0.01% |
79,277
-150,858
| -66% | -$11M |
|
1725
Robert Half
RHI
$4.04B
| $5.64M | ﹤0.01% |
56,195
-50,735
| -47% | -$4.97M |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.